Evidence Question
Does Dapagliflozin improve serum ctx-1?
Related to: Diabetic Kidney DiseaseShort answer
Current evidence does not show a clear benefit of Dapagliflozin for serum ctx-1.
Evidence at a glance
- Evidence strength
- Emerging Evidence
- Supporting research
- 1 study
- Randomized trials
- 1 trial
Why do we say this?
Across 1 randomized trial, the consistency of findings is unclear, the evidence does not yet establish a clear effect on serum ctx-1 with Dapagliflozin.
Context and limitations
- Only one supporting study is available.
Explore the evidence
Supporting research
1 published study